BI-6901 |
BI-6901 : Antagonist of CCR10
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CCR10 |
|
Antagonist
100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
No meaningful binding or activity was observed against 29 GPCR’s, including 6 chemokine receptors (s ...
Potency Cellular
In Vitro
CCR10
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2016.09.047
In Vivo Validations
Mouse
Dose: 100 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
<3 min
Systemic clearance:
>88% QH
Fb :
99%
DOI Reference: 10.1016/j.bmcl.2016.09.047
Negative Control Compounds
CANSAR3872900
Notes: BI-6902 is the optical antipode of BI-6901 and inhibits the CCL27 dependent Ca2+ flux in CHO-K cells stably transfected with human CCR10 and aequorin with an pIC50 5.5. It was used as a negative control in in vivo pharmacology experiments
Chemical Information
| Molecular Formula | C23H27N5O3S |
| SMILEs | CC1CCN(C(=O)[C@@H](CCn2cccc2C#N)NS(=O)(=O)c2cccc3[nH]ccc23)CC1 |
| InChI | InChI=1S/C23H27N5O3S/c1-17-8-13-28(14-9-17)23(29)21(10-15-27-12-3-4-18(27)16-24)26-32(30,31)22-6-2-5-20-19(22)7-11-25-20/h2-7,11-12,17,21,25-26H,8-10,13-15H2,1H3/t21-/m1/s1 |
| Molecular weight | 453.18 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 59 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.